Circulating levels of stromal cell-derived factor 1α and interleukin 7 in HIV type 1 infection and pulmonary tuberculosis are reciprocally related to CXCR4 expression on peripheral blood leukocytes

AIDS Research and Human Retroviruses

Volumn 19, Issue 6, 2003, Pages 461-468

  Shalekoff, Sharon ^a   Tiemessen, Caroline T ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYTOKINE; INTERLEUKIN 7; STROMAL CELL DERIVED FACTOR 1ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE; MAJOR CLINICAL STUDY; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL; T LYMPHOCYTE; TUBERCULOSIS; VIRUS LOAD;

EID: 0038003198     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922203766774504     Document Type: Article

References (40)

1. Theuer CP, Hopewell PC, Elias D, Schecter GF, Rutherford GW, and Chaisson RE: Human immunodeficiency virus infection in tuberculosis patients. J Infect Dis 1990;162:8-12.
2. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, and Ellner J: Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med 1995;151:129-135.
3. Whalen C, Horsburgh CR, Jr., Hom D, Lahart C, Simberkoff M, and Ellner J: Site of disease and opportunistic infection predict survival in HIV-associated tuberculosis. AIDS 1997;11:455-460.
4. Leroy V, Salmi LR, Dupon M, Sentilhes A, Texier-Maugein J, Dequae L, Dabis F, and Salamon R: Progression of human immunodeficiency virus infection in patients with tuberculosis disease: A cohort study in Bordeaux, France, 1988-1994. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Am J Epidemiol 1997;145:293-300.
5. Whalen CC, Nsubuga P, Okwera A, Johnson JL, Hom DL, Michael NL, Mugerwa RD, and Ellner JJ: Impact of pulmonary tuberculosis on survival of HIV-infected adults: A prospective epidemiologic study in Uganda. AIDS 2000;14:1219-1228.
6. Zhang Y, Nakata K, Weiden M, and Rom WN: Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995;95:2324-2331.
7. Tashiro K, Tada H, Heilker R, Shirozu M, Nakano T, and Honjo T: Signal sequence trap: A cloning strategy for secreted proteins and type I membrane proteins. Science 1993;261:600-603.
8. Nagasawa T, Kikutani H, and Kishimoto T: Molecular cloning and structure of a pre-B-cell growth-stimulating factor. Proc Natl Acad Sci USA 1994;91:2305-2309.
9. Jiang W, Zhou P, Kahn SM, Tomita N, Johnson MD, and Weinstein IB: Molecular cloning of TPAR1, a gene whose expression is repressed by the tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA). Exp Cell Res 1994;215:284-293.
10. D'Apuzzo M, Rolink A, Loetscher M, Hoxie JA, Clark-Lewis I, Melchers F, Baggiolini M, and Moser B: The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. Eur J Immunol 1997;27:1788-1793.
11. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, and Springer TA: A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996;184:1101-1109.
12. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, and Kishimoto T: Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996;382:635-638.
13. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, Kitamura Y, Matsushima K, Yoshida N, Nishikawa S, Kishimoto T, and Nagasawa T: The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998;393:591-594.
14. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, and Littman DR: Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599.
15. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, and Springer TA: The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996;382:829-833.
16. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana-Seisdedos F, Schwartz O, Heard JM, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, and Moser B: The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature 1996;382:833-835.
17. Feng Y, Broder CC, Kennedy PE, and Berger EA: HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996;272:872-877.
18. Namen AE, Schmierer AE, March CJ, Overell RW, Park LS, Urdal DL, and Mochizuki DY: B cell precursor growth-promoting activity: Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988;167:988-1002.
19. Wolf SS and Cohen A: Expression of cytokines and their receptors by human thymocytes and thymic stromal cells. Immunology 1992;77:362-368.
20. Fernandez E, Vicente A, Zapata A, Brera B, Lozano JJ, Martinez C, and Toribio ML: Establishment and characterization of cloned human thymic epithelial cell lines: Analysis of adhesion molecule expression and cytokine production. Blood 1994;83:3245-3254.
21. Conlon PJ, Morrissey PJ, Nordan RP, Grabstein KH, Prickett KS, Reed SG, Goodwin R, Cosman D, and Namen AE: Murine thymocytes proliferate in direct response to interleukin-7. Blood 1989;74:1368-1373.
22. Gringhuis SI, de Leij LF, Verschuren EW, Borger P, and Vellenga E: Interleukin-7 upregulates the interleukin-2-gene expression in activated human T lymphocytes at the transcriptional level by enhancing the DNA binding activities of both nuclear factor of activated T cells and activator protein-1. Blood 1997;90:2690-2700.
23. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D, Buchbinder S, Vittinghoff E, Goedert JJ, O'Brien TR, Jacobson LP, Detels R, Donfield S, Willoughby A, Gomperts E, Vlahov D, Phair J, and O'Brien SJ: Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 1998;279:389-393.
24. Mummidi S, Ahuja SS, Gonzalez E, Anderson SA, Santiago EN, Stephan KT, Craig FE, O'Connell P, Tryon V, Clark RA, Dolan MJ, and Ahuja SK: Genealogy of the CCR5 locus and chemokine system gene variants associated with altered rates of HIV-1 disease progression. Nat Med 1998;4:786-793.
25. Easterbrook PJ, Rostron T, Ives N, Troop M, Gazzard BG, and Rowland-Jones SL: Chemokine receptor polymorphisms and human immunodeficiency virus disease progression. J Infect Dis 1999;180:1096-1105.
26. Soriano A, Martinez C, Garcia F, Plana M, Palou E, Lejeune M, Arostegui JI, De Lazzari E, Rodriguez C, Barrasa A, Lorenzo JI, Alcami J, Del Romero J, Miro JM, and Gallart T: Plasma stromal cell-derived factor (SDF)-1 levels, SDF1-3′A genotype, and expression of CXCR4 on T lymphocytes: Their impact on resistance to human immunodeficiency virus type 1 infection and its progression. J Infect Dis 2002;186:922-931.
27. + cell count in human immunodeficiency virus type 1-infected individuals. AIDS Res Hum Retroviruses 1999;15:1063-1071.
28. Ikegawa M, Yuan J, Matsumoto K, Herrmann S, Iwamoto A, Nakamura T, Matsushita S, Kimura T, Honjo T, and Tashiro K: Elevated plasma stromal cell-derived factor 1 protein level in the progression of HIV type 1 infection/AIDS. AIDS Res Hum Retroviruses 2001;17:587-595.
29. Llano A, Barretina J, Blanco J, Gutierrez A, Clotet B, and Este JA: Stromal-cell-derived factor 1 prevents the emergence of the syncytium-inducing phenotype of HIV-1 in vivo. AIDS 2001;15:1890-1892.
30. Llano A, Barretina J, Gutierrez A, Blanco J, Cabrera C, Clotet B, and Este JA: Interleukin-7 in plasma correlates with CD4 T-cell depletion and may be associated with emergence of syncytium-inducing variants in human immunodeficiency virus type 1-positive individuals. J Virol 2001;75:10319-10325.
31. Smithgall MD, Wong JG, Critchett KE, and Haffar OK: IL-7 up-regulates HIV-1 replication in naturally infected peripheral blood mononuclear cells. J Immunol 1996;156:2324-2330.
32. Pedroza-Martins L, Boscardin WJ, Anisman-Posner DJ, Schols D, Bryson YJ, and Uittenbogaart CH: Impact of cytokines on replication in the thymus of primary human immunodeficlency virus type 1 isolates from infants. J Virol 2002;76:6929-6943.
33. Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, Steinberg SM, Wood LV, Yarchoan R, Zuckerman J, Landay A, and Mackall CL: A potential role for interleukin-7 in T-cell homeostasis. Blood 2001;97:2983-2990.
34. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, Herzenberg LA, Herndier BG, Andersson J, and McCune JM: Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: Implications for T-cell homeostasis. Nat Med 2001;7:73-79.
35. Shalekoff S, Pendle S, Johnson D, Martin DJ, and Tiemessen CT: Distribution of the human immunodeficiency virus coreceptors CXCR4 and CCR5 on leukocytes of persons with human immunodeficiency vims type 1 infection and pulmonary tuberculosis: Implications for pathogenesis. J Clin Immunol 2001;21:390-401.
36. Amara A, Gall SL, Schwartz O, Salamero J, Montes M, Loetscher P, Baggiolini M, Virelizier JL, and Arenzana-Seisdedos F: HIV coreceptor downregulation as antiviral principle: SDF-1α-dependent internalization of the chemokine receptor CXCR4 contributes to inhibition of HIV replication. J Exp Med 1997;186:139-146.
37. + human memory T cells. J Immunol 2000;165:716-724.
38. Bolotin E, Annett G, Parkman R, and Weinberg K: Serum levels of IL-7 in bone marrow transplant recipients: Relationship to clinical characteristics and lymphocyte count. Bone Marrow Transplant 1999;23:783-788.
39. Mastroianni CM, Forcina G, d'Ettorre G, Lichtner M, Mengoni F, D'Agostino C, and Vullo V: Circulating levels of interleukin-7 in antiretroviral-naive and highly active antiretroviral therapy-treated HIV-infected patients. HIV Clin Trials 2001;2:108-112.
40. Morris L, Cilliers T, Bredell H, Phoswa M, and Martin DJ: CCR5 is the major coreceptor used by HIV-1 subtype C isolates from patients with active tuberculosis. AIDS Res Hum Retroviruses 2001;17:697-701.